TRANSCODE THERAPEUTICS INC
CUSIP 89357L105
Transcode Therapeutics Inc has 13 institutional holders in Filings Flow’s 13F database, together reporting 265.2K shares worth $67,785 as of Q4 2022. The largest reported holders are Geode Capital Management, LLC, Sheets Smith Wealth Management, and One68 Global Capital, LLC.
Institutional Holders
13
Q4 2022
Reported Value
$67,785
Ticker
unmapped
private placement or foreign
Quarters Tracked
2
Ownership Trend
Institutional holders
Total reported value
Holders
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| SHEETS SMITH WEALTH MANAGEMENT$1.0B AUM | 0.00% | $20,310 | 60.0K | Q1 2023 |
| Warberg Asset Management LLC$600M AUM | 0.00% | $6,770 | 20.0K | Q1 2023 |
| Shay Capital LLC$1.2B AUM | 0.00% | $5,098 | 15.1K | Q1 2023 |
| Tower Research Capital LLC (TRC)$3.8B AUM | 0.00% | $2,000 | 6.4K | Q1 2023 |
| TWO SIGMA INVESTMENTS, LP$123.9B AUM | 0.00% | $6,569 | 19.4K | Q1 2023 |
| GEODE CAPITAL MANAGEMENT, LLC$1.61T AUM | 0.00% | $25,641 | 75.7K | Q1 2023 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.